A physicians’ organization has written to Arizona Gov. Doug Ducey asking him to back off his ban on two medicines used to treat coronavirus because of studies that show they work.
It’s because studies have shown that about nine of 10 patients who have access to it respond well.
It is the Association of American Physicians and Surgeons that is asking the governor to reverse his outright ban on the use of anti-malaria drugs chloroquine and hydroxychloroquine against the Chinese coronavirus, for which there is yet no vaccine.
To date, the total number of reported patients treated with HCQ, with or without zinc and the widely used antibiotic azithromycin, is 2,333, the AAPS explained.
TRENDING: Watch Biden lapse into utter nonsense when pressed on China and son Hunter
Those cases are from China, France, South Korea, Algeria, and the U.S.
“Of these, 2,137 or 91.6 percent improved clinically. There were 63 deaths, all but 11 in a single retrospective report from the Veterans Administration where the patients were severely ill,” the organization reported.
“The antiviral properties of these drugs have been studied since 2003. Particularly when combined with zinc, they hinder viral entry into cells and inhibit replication. They may also prevent overreaction by the immune system, which causes the cytokine storm responsible for much of the damage in severe cases,” the doctors explained.
Already, HCQ is often very helpful in treating autoimmune diseases such as lupus and rheumatoid arthritis.
Further, some studies show a decrease in the number of days when a patient is contagious, a reduction in the need for ventilators, and a shortened time to clinical recovery.
“Peer-reviewed studies published from January through April 20, 2020, provide clear and convincing evidence that HCQ may be beneficial in COVID-19, especially when used early,” the organization reported.
“Unfortunately, although it is perfectly legal to prescribe drugs for new indications not on the label, the Food and Drug Administration (FDA) has recommended that CQ and HCQ should be used for COVID-19 only in hospitalized patients in the setting of a clinical study if available. Most states are making it difficult for physicians to prescribe or pharmacists to dispense these medications,” the organization reported.
The letter to Ducey explains, “Many nations, including Turkey and India, are protecting medical workers and contacts of infected persons prophylactically. According to worldometers.info, deaths per million persons from COVID-19 as of Apr 27 are 167 in the U.S., 33 in Turkey, and 0.6 in India.”
The letter to Ducey was signed by Michael Robb, M.D., of the Arizona chapter of AAPS, and Jane Orient, M.D., executive director of the national organization.
